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Social anxiety disorder (SAD) is a prevalent chronic condition with a large 
demand for treatment. This community outpatient study examined the effectiveness of a 
group intervention version of the established one-to-one cognitive therapy derived from 
the Clark and Wells model for SAD. Questionnaires were completed pre-treatment and 
post-treatment for SAD symptoms (Social Phobia Scale, Social Interaction Anxiety 
Scale), depressive symptoms (BDI-II), self-focused attention, safety behaviours (Social 
Phobia Weekly Summary Scale and Subtle Avoidance Frequency Examination, and 
impaired functioning (Work and Social Adjustment Scale). From an initial sample of 
159 participants, 101 completed at least seven of the nine weekly group sessions (Mage = 
34.1 years, SDage = 10.8 years, 53% female). Significant improvements were 
demonstrated on all measures. Large effect sizes were found for social anxiety 
symptoms and safety behaviour use. Self-focused attention depressive symptoms and 
impaired functioning had moderate effect sizes. Effect sizes for anxiety (d = 1.00 and 
1.32) and mood measures (d = 0.71) were as high, or in some cases, higher than 
previous group treatment studies. Results suggest group cognitive therapy for SAD 
based on the Clark and Wells model is effective in a clinical setting for individuals with 
moderate/severe and treatment resistant social anxiety. 
 




Social anxiety disorder (SAD) is the marked fear or anxiety about social 
situations in which the individual may be exposed to the possible scrutiny of others 
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(American Psychiatric Association, 2013). It affects a sizeable proportion of the 
population, with an estimated lifetime prevalence of 12.1% and a 12-month prevalence 
of 7.1% in the USA (Ruscio et al., 2008). Other countries report similar 12-month rates 
(Iancu et al., 2006); such as 4.7% in Australia (Slade, Johnston, Oakley Brown, 
Andrews, & Whiteford, 2009), 5.1% in New Zealand (Ministry of Health, 2012), and up 
to 7.9% in European nations (Wittchen et al., 2011). The average onset age for SAD is 
early adolescence (Ollendick & Hirshfeld-Becker, 2002), with the condition generally 
following a chronic and unremitting course across the life span (Albano & Hayward, 
2004). 
Despite the prevalence and chronic course of SAD, there is often limited time 
and resources to provide treatment (Goldin et al., 2016).  The National Institute for 
Health and Care Excellence (NICE, 2013) recommends individual cognitive behaviour 
therapy (CBT) as the first-line treatment. Further support for this recommendation was 
provided by a recent meta-analysis of 101 trials of psychological and pharmacological 
interventions for SAD (n = 13,164) (Mayo-Wilson et al., 2014).  A corresponding 
economic analysis similarly reported that individual CBT (based on the Clark and 
Heimberg models) was the most cost-effective (Mavranezouli et al., 2015). While there 
are a number of alternative approaches to delivering cognitive behaviour therapy 
(CBT), such as internet based and intensive treatments, results of the Mayo et al. review 
concluded that individual CBT, including cognitive therapy based on Clark and Wells 
(1995) model, consistently demonstrated the greatest effect sizes. Furthermore, that 
group CBT compared favourably with individual approaches (Mayo-Wilson et al., 
2014). However, despite the reported effectiveness of group-based CBT, this treatment 
approach does have potential limitations, for example, lack of individualisation in terms 
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of treatment plans and strength of resulting therapeutic relationships (Hauksson, 
Ingibergsdóttir, Gunnarsdóttir, & Jónsdóttir, 2017; Sochting, 2014). 
Clark and Wells (1995) Cognitive Therapy for Social Anxiety Disorder 
(hereinafter referred to as CT-SAD) uses a wider range of therapeutic procedures, which 
aim to reverse the maintaining processes specified in the Clark and Wells model (Clark 
et al., 2006). For example, participants identify and test cognitive predictions during 
behavioural experiments where safety behaviours are dropped and later feared outcomes 
are intentionally carried out. Feared outcomes may include sweating, talking about a 
possibly boring topic, or pausing during conversation. Additional exercises encourage 
the participant to transfer their attention from themselves to the external environment in 
order to identify information that challenges their negative self-beliefs and to reduce 
self-focused attention.  
Reflecting the demand for treatment coupled with limited health service 
resources, there has been increasing interest in examining the effectiveness of 
alternative ways of delivering this therapy, for example in a group format (McCarthy, 
Hevey, Brogan, & Kelly, 2013). Some services have noted that there may be benefits of 
group treatment including normalisation of symptoms within a peer group, a social 
context within which skills can be practiced, the opportunity to learn from others, social 
pressure to comply with treatment and homework, and for some services the group 
format may be a better fit with respect to staff and financial resources (McEvoy, 2007; 
Wersebe, Sijbrandij, & Cuijpers, 2013). 
Given the robust evidence base for Clark and Wells CT-SAD it is not surprising 
that it is now the focus of attention in regard to effectively adapting it for group 
intervention (Stangier, Heidenreich, Peitz, Lauterbach, & Clark, 2003).  However, only 
a limited number of studies have adapted CT-SAD into varying forms of group therapy, 
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with differing degrees of adherence to CT-SAD and its treatment protocol. One study of 
71 adults with SAD evaluated individual cognitive therapy, with a predominant CT-
SAD treatment focus, in comparison to a group version of this program (Stangier et al., 
2003). While both protocols aligned closely to CT-SAD, they did incorporate additional, 
specific cognitive work focussed on targeting assumptions, which is not part of Clark’s 
CT-SAD standard protocol.  Both treatments resulted in significant improvement in 
social anxiety on the Social Phobia Scale (SPS; Mattick & Clarke, 1998), Social 
Interaction Anxiety Scale (SIAS; Mattick & Clarke, 1998), and Social Phobia and 
Anxiety Inventory (SPAI; Turner, Beidel, Dancu, & Stanley, 1989). However, the 
individual format showed larger effect sizes at post-treatment: 0.90, 0.85, and 1.77 for 
the SPS, SIAS, and SPAI respectively for individual vs. 0.53, 0.53 and 0.60 for group 
(Stangier et al., 2003). On measures of mood, using the Beck Depression Inventory 
(BDI-II; Beck, Steer, & Brown, 1996), the group version showed significant 
improvement, whereas the individual format did not. The authors concluded that 
individual therapy was more effective than the group version in reducing the symptoms 
of social anxiety but noted that the therapists had limited training and that the study 
should be considered exploratory.  
A further longitudinal study of 252 participants with SAD examined the 
effectiveness of a community-based group intervention, based on CT-SAD (McCarthy 
et al., 2013). However, McCarthy et al.’s intervention included some adaptations that 
were not consistent with Clark’s CT-SAD protocol, such as cognitive restructuring and 
positive data logs. Measures were collected pre-treatment, post-treatment and at 12 
months’ follow-up and showed significant reductions in SAD symptoms and general 
mood measures. As the majority of participants were self-referred, findings may have 
been impacted by a less avoidant and more motivated subset. Further, while the Stangier 
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et al. (2003) and McCarthy et al. (2013) studies investigated CT-SAD in a group format 
and demonstrated positive findings, both studies indicated  limitations relating to 
therapists, participants, and included variations from Clarks’ standard CT-SAD protocol. 
Nonetheless, these findings support the proposition that CT-SAD can be incorporated 
into group treatment settings with positive outcomes.  
A final point, Shafran et al. (2009) highlighted the commonly held criticism that 
CBT research trials may not be generalisable to routine settings and emphasised that 
this assumption may act as a barrier to the dissemination of evidence-based CBT.  
Shafran et al. highlighted that there was increasing evidence that research trials’ 
findings are applicable to routine clinical care settings. Accordingly, Gunter and Whittal 
(2010) recommended that further effectiveness studies (i.e., non-research centre 
outcomes) were required to contribute to the argument that CBT for anxiety disorders 
should be widely disseminated.   
Based on the saliency of this topic area and limitations of previous research, the 
current study examined the effectiveness of Clark’s CT-SAD protocol developed into a 
group therapy intervention (GCT-SAD) in a routine, clinical setting with patients who 
had not responded to psychological and pharmacological interventions in the 
community. Based on the substantial evidence for the CT-SAD approach in an 
individual format at reducing the symptoms of anxiety, improving mood, and reducing 
self-focused attention and safety behaviours, it was hypothesised we would find similar 
effectiveness results for a newly-developed, group format in an out-patient clinic.  
The following research hypotheses were tested; that after group treatment: (1) 
there would be a statistically significant decrease in social anxiety symptoms in 
participants, as measured by the SPS and the SIAS (Mattick & Clarke, 1998); (2) there 
would be a statistically significant decrease in depression symptoms in participants, as 
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measured by the BDI-II (Beck et al., 1996); (3) there would be a decrease in measures 
of self-focused attention and safety seeking behaviours (as measured using one item of 
the Social Phobia Weekly Summary Scale (SPWSS; Clark et al., 2003) and the Subtle 
Avoidance Frequency Examination (SAFE; Cuming et al., 2009) respectively), as these 
are key therapy targets in the CT-SAD  model of therapy; and (4) there would be a 
reduction in measure of impaired functioning from the Work and Social Adjustment 




This study analysed changes in SAD symptoms, depressive symptoms, self-
focused attention, use of safety behaviours, and impaired functioning. Pre-treatment and 
post-treatment scores were compared using a quasi-experimental within-subjects design. 
Dependent variables analysed were SPS and SIAS scores, BDI-II scores, one item (c) of 
the SPWSS, SAFE scores, and WSAS scores.  
 
Participants and setting 
Patients under the care of the XXXX Service (XXXX), New Zealand, were 
included in this study, which took place over four years (2010-2014). The XXXX is a 
government funded public mental health service that follows a stepped care approach 
encouraging General Practitioners (GPs) to treat mild anxiety presentations with 
psychoeducation and moderate anxiety being offered counselling, community support 
workers or medication.  XXXX only accepts referrals for adults (aged 18-65) with 
moderate/severe anxiety disorders who have not responded to pharmacological and 
counselling interventions in the community. All patients had a 90 minute clinical 
SOCIAL ANXIETY GROUP COGNITIVE THERAPY 8 
 
assessment semi-structure interview conducted by a senior clinician (i.e., clinical 
psychology, mental health nurse, social worker, occupational therapist) with substantial 
experience in assessing and treating anxiety disorders. This was followed by a review 
with a multidisciplinary team under the lead of a consultant psychiatrist for verification 
of a DSM-IV diagnosis.  
After patients were assessed and accepted into the service, they were offered 
group or individual treatment; our research focus was only on those who accepted group 
treatment. GCT-SAD inclusion criteria required participants to have a primary diagnosis 
of SAD, to be suitable and willing to be involved in group treatment, and to be able to 
read English. Participants with substance dependence were not accepted into the 
service. Those with acute risk of suicide were treated with individual therapy.  
The patients were not randomised into groups but entered them as they became 
available. Some patients were initially hesitant to participate in group therapy; however, 
clinicians provided education about the group to dispel misconceptions and demystify 
treatment, normalised their apprehension, and socialised patients to the approach. From 
a sample of 168 patients who fulfilled the inclusion criteria, nine were excluded from 
the current research (e.g., declined to participate in research, no pre-treatment session), 
resulting in a final sample of 159 who fulfilled the inclusion criteria. Of note, the 
participants in this study were affected by earthquakes which started in Christchurch 
from 2010. The first treatment group occurred between two major earthquakes and the 
remaining groups were exposed to ongoing aftershocks that occurred from 2010 
onwards with diminishing frequency.  
 
Procedure and the group treatment 
Prior to treatment, participants attended an individual cognitive behavioural 
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assessment and formulation session. This session further confirmed the DSM-IV 
diagnosis of SAD, explained what GCT-SAD would involve, and developed their own 
personalised version of the Clark and Wells (1995) model of SAD and set treatment 
goals. Informed written consent for treatment and research, and pre-treatment 
questionnaires were completed at this time.  
Participants then attended nine weekly, four-hour sessions of GCT-SAD, with 
groups consisting of seven to nine participants. Two clinicians (i.e., clinical 
psychologist, registered nurse, social worker, occupational therapist) specialising in the 
cognitive behavioural treatment of anxiety disorders were allocated to each group. At 
least one of the clinicians had run at least two social anxiety disorder groups previously 
and had previous experience in using the Clark and Wells treatment modules (Clark et 
al., 2004). All clinicians received supervision from senior clinical psychologists from 
within the team who were well versed in Clark’s approach. In addition, the senior 
clinical psychologists provided additional group training on Clark’s SAD approach and 
techniques to the ADS therapists running the groups. Group content was reviewed with 
the team over time to maintain adherence to the treatment model. 
The GCT-SAD program was based on a series of modules that were originally 
developed for a self-study assisted version of the treatment (Clark et al., 2004) and were 
further adapted by the XXXX for group therapy. The modules were given to 
participants at the beginning of treatment as a reference for the content to be covered in 
the group and they were asked to complete the relevant modules as part of their weekly 
homework. GCT-SAD content included: socialising people to the Clark and Wells 
model; psychoeducation about anxiety and cognitive therapy; letting go of self-focused 
attention; attention training; reducing the use of safety behaviours; dropping of worry 
before entering social situations and going over past events; improving self-image; and 
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lastly, developing a therapy blueprint. Substantial time throughout GCT-SAD was 
focused on behavioural experiments personalised to each individual to test out cognitive 
predictions, and reduce safety behaviours and avoidance, and in vivo behavioural 
experiments were conducted during some sessions.  These included practicing 
conversations while utilising external focus, visiting malls, and experiments where the 
person purposefully drew attention to themselves or acted in ways they believed to be 
unacceptable or that did not fit with their social rules (e.g., making a mistake, saying 
something disagreeable, or wearing silly hats).  Participants were videoed giving 
speeches or other individually targeted behavioural experiments and these were played 
back to facilitate belief change through viewing themselves objectively in comparison 
to their internal, distorted self-image. Homework was integral; participants worked on 
behavioural experiments relating to their individual goals, practiced skills they had 
learnt, re-watched their videos, and completed the relevant modules. Within one to two 
weeks of each groups’ completion, participants met with a group therapist to review 
their progress. Post-treatment questionnaires were completed individually. 
Ethical approval for the study was provided by the New Zealand Health and 
Disability Ethics Committee (Ethics ref: URA/10/04/027). 
 
Measures 
Social Phobia Scale (SPS; Mattick & Clarke, 1998) and Social Interaction 
Anxiety Scale (SIAS; Mattick & Clarke, 1998) were used to measure social anxiety. 
These widely used scales measure performance and interaction anxiety respectively. 
The 20-item SPS measures the fear of being observed by others, while the 19-item SIAS 
measures fears of general social interaction. Both scales adopt a 5-point response scale 
(0 = not at all true to 4 = extremely true). Thus, high scores represent greater levels of 
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social anxiety. Both the SPS (α = .89) and SIAS (α = .93) have high internal reliability 
(Cox, Ross, Swinson, & Direnfeld, 1998).  
 Beck Depression Inventory-II (BDI-II; Beck et al., 1996) measures depressive 
symptoms for the past two weeks, with 21-items rated on a 4-point response scale (0 = I 
do not feel unhappy to 3 = I am so unhappy that I can’t stand it). Levels of severity are 
indicated as: Minimal 0 to 13; mild 14 to 19; moderate 20 to 28; and severe 29 to 63. 
The reliability and validity of the BDI-II is well established, with an internal reliability 
of .86 and test re-test reliability of .93 (McEvoy, 2007).  
Social Phobia Weekly Summary Scale; item c (SPWSS; Clark et al., 2003).   A 
single item from the 6-item SPWSS was used: “For social situations in general, please 
choose a number from the scale below to show the extent to which your attention was 
focused on yourself or on the external situation in the last week.” The item was scored 
on a 9-point scale (0 = entirely externally-focused to 8 = entirely self-focused) with 
higher scores representing a more self-focused attention. The SPWSS has good internal 
consistency (α = .81), and is sensitive to treatment effects (Clark et al., 2006; Clark et 
al., 2003).   
Subtle Avoidance Frequency Examination (SAFE; Cuming et al., 2009) was used 
to measure the frequency of social safety behaviour use. The SAFE is a 32-item 
measure, adopting a 5-point response scale (1 = never to 5 = always). The three main 
factors within this scale are: Inhibiting/restricting behaviours designed to avoid 
attracting attention (e.g., “remain silent”, “avoid eye contact”); active behaviours aimed 
at enhancing self-presentation (e.g., “rehearse sentences in your mind”); and physical 
symptom management behaviours (e.g., “wear clothes or make-up to hide blushing”). 
The scale shows high internal reliability .95, and clear convergent and divergent validity 
(Moscovitch et al., 2013).   
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Work and Social Adjustment Scale (WSAS; Hafner & Marks, 1976) was employed 
to measure the degree of interference caused by symptoms. The WSAS is a 5-item 
measure, adopting a 9-point response scale (0 = not at all to 8 = very severely). The 5-
items include work, home management, social leisure activities, private leisure 
activities, and family and relationships. The scale has a possible total score of 40, with 
scores above 20 suggesting moderate to severe pathology (Mundt, Marks, Shear, & 
Greist, 2002). The measure has shown adequate test-retest reliability of .73, (Mundt et 
al., 2002), and good internal consistency .80 (Allen et al., 2009). 
For the current sample, questionnaire internal consistencies (with the exception 
of the WSAS α = .67) were all satisfactory (SPS α = .92, SIAS α = .84, BDI-II α = .92, 
SPWSS α = .73, SAFE α = .88). The Cronbach’s alpha for the WSAS, a 5-item scale, 
may have been due to the limited number of items in the scale. The value of the alpha is 
dependent on the number of items in the scale and as the number of items in a scale 
increases the alpha will increase (Field, 2013). Further, the WSAS has shown good 
internal reliability in other studies (Allen et al., 2009). Therefore, it was decided to 
leave the questionnaire intact rather than deleting items in an attempt to increase the 
alpha.  
Data analyses 
SPSS (version 24) was used for statistical analyses. The self-reported data 
consisted of anxiety levels as represented by scores on the SPS and SIAS; depression 
levels as represented by BDI-II scores; levels of self-focus as reported by the item c 
score of the SPWSS scale; levels of safety seeking behaviours as represented by SAFE 
scores; and functioning as represented by the WSAS. Data were manually entered into 
SPSS. To ensure accuracy of data-entry a 10% audit, comparing the original data set 
provided by XXXX against the SPSS data set, was conducted. With regard to missing 
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data, scale data were included if 95% or more of the scale had been completed. While 
there is little consensus in the literature regarding an acceptable missing data cut-off rate 
(Dong & Peng, 2013), Bennett (2001) maintains that when the amount of missing data 
is greater than 10%, statistical analyses may be biased. Therefore, the exclusion rate of 
5% or less was considered to be an acceptable range. Adjustments for missing data, for 
participants with missing data but not excluded, were made using a prorated 
methodology.  
Data screening was conducted to ensure that appropriate assumptions were met. 
The Shapiro-Wilk test indicated a possible breach in normality in one instance, SPS 
post-treatment; however, visual inspection of the normal Q-Q plot and histogram for 
this scale confirmed normality. Further, it was noted that care must be taken when using 
the Shapiro-Wilk test on larger sample sizes as significant results may occur for even 
slight deviations (Field, 2013). In consideration of the robustness of the data, there was 
no need to conduct transformations.  
Dependent samples t-tests require normality of the differences between the 
scores on each dependent variable. All variables showed appropriate skewness and 
kurtosis values. Further, the difference scores between all variables were normally 
distributed, as assessed by visual inspection of the normal Q-Q plots. Nine outliers were 
detected, as assessed by visual inspection of box-plots. Inspection of these values did 
not reveal them to be extreme and they were kept in the analysis.   
Pre-treatment completer / non-completer group equivalence on demographic and 
psychological measures was assessed by t-tests and Chi-square analysis as appropriate. 
Paired samples t-tests were used to compare differences pre- and post-treatment in 
completers’ scores. An a priori decision was to define completion as an adequate dose 
of therapy as attendance of at least seven out of nine treatments sessions based on 
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previous research at XXXX and studies on group therapy (Bell, Colhoun, Carter, & 
Frampton, 2012; Sloan, Feinstein, Gallagher, Beck, & Keane, 2013). To ensure that 
effect sizes were not artificially inflated due to experimental mortality type effects, 
effect sizes were calculated using both completers’ and intention-to-treat (ITT) data. In 
accordance with previous research (e.g., McEvoy, 2007), effect sizes were computed 
using the formula (pre-treatment mean – post-treatment mean) / pre-treatment standard 
deviation. Effect sizes magnitude interpretations were based on Cohen’s d, with d = 0.20 
considered small effect, d = 0.50 considered medium effect, and d = 0.80 considered 
large effect (Cohen, 1988). Power (1 – β) was set at .80 and alpha at .05.  
Results 
Sample characteristics 
Participants (n =159) were classified into completers and non-completers (see 
above definition); 101 (64%) participants were deemed treatment completers (N = 101, 
Mage = 34.1 years, SDage = 10.8 years, range 19 - 59 years; 53% female) and 58 (36%) 
participants were deemed non-completers (Mage = 33.6 years, SDage = 10.1 years, range 
20 - 59 years; 52% female) (see Figure 1). Of the non-completers, 14 participants had 
dropped-out after the initial assessment; a further seven after session 1; five after 
session 2; five after session 3; eight after session 4; six after session 5; and 13 after 
session 6. Of the completer group, 80% were NZ/European, 5% Maori, and 15% other. 
Nearly a third of completers, 28%, were cohabitating or married, 66% had a high school 
education, 16% had tertiary education, 13% had a trade or technical certificate, and 5% 
had primary education only. Additionally, 45% of completers were unemployed. 
Reflecting the severity and treatment resistant state of the participants, all were on 
psychotropic medication, predominantly anti-depressants, two-thirds of whom did not 
change their medication during the course of GCT-SAD. Of the treatment completers, 
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84% participants reported no comorbidities, 4% reported generalised anxiety disorder, 
4% panic disorder with agoraphobia, 3% depressive disorder, 3% obsessive compulsive 
disorder, 1% panic disorder, and 1% reporting obsessive compulsive disorder with 
generalised anxiety disorder. 
Completers (n = 99) were not significantly different to non-completers (n = 58) 
on any demographic or psychological measure (p > .05). Reasons cited for attrition from 
the study were psychosocial issues (lack of transport, loss of housing, finding work, 
illness), or psychological issues (too anxious to attend).  
Descriptive statistics 
This study analysed changes in SAD symptoms, depressive symptoms, self-
focused attention, use of safety behaviours, and impaired functioning. Pre-treatment and 
post-treatment scores were compared using a quasi-experimental within-subjects design. 
Dependent variables analysed were SPS and SIAS scores, BDI-II scores, one item of the 
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SPWSS, SAFE scores, and WSAS scores.  
Pre-treatment and post-treatment comparisons 
Means and standard deviations for all dependent variables, pre- and post-
treatment are shown in Table 1.  Mean scores of 45.31 and 53.16 on the SPS and the 
SIAS respectively indicate high levels of social anxiety.  BDI-II mean score of 25.8 
indicate moderate levels of depression and 24.01 on the WSAS suggest moderately 
severe pathology which gives an indication of the severity of this sample. 
Significant and meaningful improvements (as indicated by moderate to large 
effect sizes) were demonstrated on all measures. The results demonstrated that overall the 
GCT-SAD participants had statistically significant decreases in symptoms of social 
anxiety (SPS and SIAS; large effect sizes), depression (BDI-II; medium effect size), self-
focused attention (SPWSS item c; medium effect size) and safety behaviours (SAFE; 
large effect size) and significant improvement in occupational, social and domestic 
functioning (WSAS; medium effect size).  
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Note. SPS = Social Phobia Scale; SIAS = Social Interaction Anxiety Scale; BDI-II = 
Beck Depression Inventory II; SPWSS (c) = Social Phobia Weekly Summary Scale 
Item c; SAFE = Subtle Avoidance Frequency Scale; WSAS = Work and Social 
Adjustment Scale.  Effect sizes were calculated using an Intention-to-Treat (ITT) 
approach including all participants’ data; pre- and post-treatment means (standard 
deviations) were calculated using completers’ data only. Initial group equivalents 
between those that went on to be completers and those who were non-completers was 
assumed by non-significant (p > .05) independent t-tests at pre-treatment. * p < .001. 
†While 101 participants gave useful data at both pre and post, not all participants 
provided responses across all measures at both time points, thus n < 101. Further, not all 




The aim of the current study was to determine the effectiveness of Clark and 
Wells CT-SAD developed into a group therapy intervention, GCT-SAD, in a routine 
clinical setting. It was hypothesised that after group treatment: (1) There would be a 
statistically significant decrease in social anxiety symptoms in participants; (2) there 
would be a statistically significant decrease in depression symptoms in participants; (3) 
there would be a decrease in measures of self-focused attention and safety seeking 
behaviours; and (4) there would be a reduction of impaired functioning. The present 
findings strongly suggest that this therapy format was effective with individuals 
suffering from severe SAD (with large effect size). The specific social anxiety disorder 
measures demonstrated greater change than the general mood measures, with the largest 
gains on the SPS (d = 1.0) and SIAS (d = 1.32) scales. This result does raise the 
question of whether the other measures of BDI-II, SPWSS(c), SAFE, and WSAS 
weren’t so sensitive to change, or that the treatment did not produce such large 
improvements for those symptoms as compared to the social anxiety disorder 
symptoms. Based on the reported utility of the measures, we were confident the result 
was more due to the effect of intervention, rather than insensitive measurement issues. 
Regarding our first hypothesis, there was a significant decrease in SAD. These 
improvements are noteworthy as the participants had not responded well to previous 
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treatments; the participants for this investigation were only accepted as referrals if they 
had moderate/severe anxiety disorders and had not responded to pharmacological and 
counselling interventions in the community.  It is also important to note that the 
participants’ high baseline levels of social anxiety were comparable to other studies 
(Clark et al., 2003; Gaston, Abbott, Rapee, & Neary, 2006; Mörtberg, Karlsson, Fyring, 
& Sundin, 2006; Stangier et al., 2003).  These high baseline levels of severity 
potentially allowed more room for improvement, consequently, making it easier to get 
larger effect sizes; although baseline severity does not always have a linear relationship 
with degree of improvement (Kirsch et al., 2008). Nevertheless, the effect sizes were as 
high, or higher than, other group treatment studies (e.g., McCarthy et al., 2013, SPS d = 
0.87, SIAS d = .97; McEvoy, 2007, SPS d = 1.00, SIAS d = 1.10). Further, GCT-SAD 
compared favourably to several individual studies for SAD (Lincoln et al., 2003; 
Stangier et al., 2003) but did not achieve the effect sizes demonstrated by CT-SAD (e.g., 
Mayo-Wilson et al., 2014) suggesting that GCT-SAD could be further improved. 
Overall, results indicate that our version of GCT-SAD is effective for significantly 
reducing anxiety symptoms in severe and treatment resistant patients.  
Anxiety and depressive disorders frequently occur together (Spijker, Muntingh, 
& Batelaan, 2020); therefore, pragmatically it is important when measuring the 
effectiveness of anxiety treatment to evaluate treatments’ impact on depression. Thus, 
with regard to the second hypothesis, the treatment process significantly decreased 
participants’ levels of depression. At pre-treatment, participants were in the moderately 
depressed range (20-28), with a BDI-II mean of 25.80, compared to other group and 
individual studies where participants started treatment with a mild BDI score (14-19; 
Mörtberg et al., 2006; Stangier et al., 2003, Lincoln et al., 2003). At post-treatment, 
participants BDI-II scores had shifted to a mild level with a moderate effect size of 0.7 
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which is consistent with findings from other group treatment studies (McCarthy et al., 
2013; McEvoy, 2007; Mörtberg et al., 2006; Stangier et al., 2003) and provides further 
evidence that directing treatment at an anxiety disorder often improves comorbid 
depression (Spijker, Muntingh, & Batelaan, 2020).  Effect sizes were lower for 
depression than social anxiety measures, likely due to GCT-SAD targeting anxiety 
symptoms rather than mood but nonetheless suggests that as peoples’ social anxiety 
improves their mood may also improve to a lesser degree.   
In relation to the third hypothesis, there were significant decreases in self-
focused attention and safety seeking behaviour associated with the improvement in 
social anxiety measures. CT-SAD specifically targets these maintaining factors as their 
reduction appears to assist in contradicting inaccurate negative beliefs and may reduce 
the possibility of feared outcomes occurring. It is likely that some of the specific 
procedures that have shown to be effective in reducing the symptoms of SAD in other 
studies utilising the Clark and Wells approach (Clark et al., 2006), such as video 
feedback, experiential demonstration of the adverse effects of self-focused attention and 
safety behaviours, and imagery modification, have had similar effects in GCT-SAD. 
Reduction in self-focused attention had a moderate effect size, and does not compare 
well with the Mörtberg, Hoffart, Boecking, and Clark (2013) study that had a large 
effect size for the SPWSS item c. While baseline levels of self-focus were similar in 
both studies, it is important to note the Mörtberg et al. (2013) efficacy study utilised an 
individual therapy approach over 16 weeks versus our group treatment duration of nine 
weeks.  The specific individual focus and a longer time-frame to practice the skill may 
explain the difference in the effect size between the two studies. However, this 
highlights that improving the method of cognitive therapy’s focus on reducing self-
focused attention in a group format needs further development and consideration.  
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The significant decrease in safety behaviours resulted in a large effect size in our 
study. As well as preventing effective processing of the social situation, it has been 
proposed that a reduction in safety behaviours may reduce self-focus (Bögels & 
Mansell, 2004; Clark & Wells, 1995; Rapee & Heimberg, 1997), although no 
mediational analysis was conducted in the present study to confirm this possibility.  
Regarding the fourth hypothesis, there were significant decreases in functional 
impairment following treatment, with a moderate effect size. This clinical characteristic 
has been found to be predictive of a stable, persisting course of SAD (Beesdo-Baum et 
al., 2012), and a reduction indicates the possibility of a return towards healthy 
functioning. SAD is known to have a relatively early age of onset and is associated with 
significant impairment in work and social functioning (Rapaport, Clary, Fayyad, & 
Endicott, 2005). While our study looked at changes pre- and post-treatment, allowing 
for perceived, self-reported improvement to be measured, it would have been useful to 
have had a clinical measurement of functioning to support these results.  
Importantly, our findings for the effectiveness of a group version of CT-SAD 
(i.e., GCT-SAD) in a routine out-patient clinic, were comparable to previous 
effectiveness and routine care treatment studies (McEvoy, 2007; McCarthy et al., 2013). 
Our effect sizes for all measures were towards the higher scores found in previous 
research. This is notable, given that all patients had not responded to previous treatment 
for SAD and although it is unlikely that they would have received prior evidence-based 
treatment for SAD, it may have reduced the placebo effect prior to their treatment at 
ADS.  Furthermore, they were also exposed to a significant natural disaster, including 
aftershocks, while experiencing SAD and during their treatment. 
 
Limitations and future directions 
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Strengths of the current study were that it used a population of clinically referred 
participants with SAD who had not responded to previous treatments, it had a large 
sample size, and treatments were conducted in a naturalistic, routine care setting. These 
factors are encouraging for generalisability of our results.  
Several limitations, however, must be considered. First, this study was impacted 
by a number of disruptions; the first group occurred between two major earthquakes, 
there were ongoing aftershocks throughout the treatment process for all groups, 
resulting in sessions being conducted in a range of settings due to the loss of the initial 
treatment building, and the location of non-clinic behavioural experiments had to be 
moved due to damage to the inner city. It is possible that these disruptions and other 
earthquake-related consequences contributed to the drop-out rate of 36.5%. While high 
drop-out rates are not uncommon in SAD literature (Bados, Balaguer, & Saldaña, 2007; 
Fedoroff & Taylor, 2001) with some studies reporting drop-out rates as high as 43.8% 
(Bados et al., 2007), a number of trials by Clark and colleagues, and other researchers, 
have demonstrated lower drop-out rates (Clark et al., 2006;  Clark et al., 2003; 
McCarthy et al., 2013).  However, Clark et al. (2006) considered completers as 
attending at least half of the therapy sessions available; whereas, in the present study we 
defined completers as completing seven of nine (75%) sessions.  Thus, different 
definitions of completers may contribute to the variability of drop-out rates. 
Nevertheless, further attention needs to be given to improving treatment retention in 
future SAD group therapy contexts. Also, given the constrictions on the extent of 
information given at referral, the exact nature of previous psychological treatments was 
unable to be determined.  In future, gathering this information may be informative in 
terms of drop-out characteristics and in determining for whom GCT-SAD may be most 
appropriate.  
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Secondly, the number of ADS patients who declined group treatment following 
their initial assessment is not known. Individual or group treatment is decided 
collaboratively between the patient and the therapist and is affected by a number of 
factors including clients’ availability for the group timetable, group start dates and 
clients’ ability to wait, and clients’ preference for individual or group format. However, 
because ADS’ process does not require group treatment as the first treatment offered, it 
is difficult to quantify the number who actually chose individual over group treatment. 
Consequently, this should be recorded more accurately in future studies.  
Thirdly, this study did not have a control group and was not a randomised 
controlled comparison of individual compared with group treatment, therefore, caution 
should be exercised in interpreting the current results.  Fourth, all data were self-
reported and self-focused attention was measured by only one item.  Although the use 
of self-report scales is common in clinical practice, such measures may be subject to 
biased responding (Sato & Kawahara, 2011) and future research could benefit from the 
addition of clinician rated scales.  Fifth, as there was no follow up data, the results only 
show short-term effects and do not allow for any conclusions regarding the maintenance 
of treatment gains. Future studies, including follow-up results, would assist in 
understanding the longer-term impact of this form of group treatment. Future research 
with larger samples could also control for depression when evaluating changes in the 
severity of social anxiety symptoms. 
Lastly, although the treatment was manualised and the team had ongoing 
processes for supervision and training, there were no formal measures of therapy 
fidelity or therapist drift. 
Conclusions 
  Given the large sample size and positive results, this study suggests that GCT-
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SAD is effective in routine, clinical care and with severe and treatment resistant 
patients. Further, our findings contribute to the growing literature supporting that 
outcomes from SAD research trials are generalisable to clinical practice. In addition, 
while it appears that our GCT-SAD format, most closely aligns to Clark’s cognitive 
therapy approach in comparison to other studies, there is scope for improvement, and 
research into the mediators of group treatment would be useful, particularly further 
research into anticipatory and post-event processing and self-focus, as these have been 
found to be key mediators in previous research (Hedman et al., 2013). Lastly, it was 
noted that GCT-SAD effect sizes were lower than CT-SAD effect sizes previously 
reported, and further comparisons between GCT-SAD and CT-SAD in a routine, 
clinical setting may be advantageous for the ongoing improvement and development of 
the group protocol. 
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